The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 21, 2016

Filed:

Oct. 03, 2012
Applicant:

National Institute of Advanced Industrial Science and Technology, Tokyo, JP;

Inventors:

Yasunori Chiba, Ibaraki, JP;

Satoshi Murakami, Ibaraki, JP;

Hisashi Narimatsu, Ibaraki, JP;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/24 (2006.01); C12N 9/42 (2006.01); C12P 21/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/2434 (2013.01); C12N 9/2402 (2013.01); C12P 21/005 (2013.01); C12Y 302/01052 (2013.01); C12Y 302/01096 (2013.01); Y02P 20/52 (2015.11);
Abstract

The present invention provides a novel endo-β-N-acetylglucosaminidase (Endo-Om) using a transformant produced by cloning an endo-β-N-acetylglucosaminidase (Endo-Om) gene originated from a methylotrophic yeastIFO10746 strain. The Endo-Om according to the present invention has a specific activity 13-fold higher than that of known Endo-M and a Vmax value 55-fold higher than that of the known Endo-M, and is useful for the analysis of the structures of sugar chains, including complex type sugar chains, in glycoproteins and the modification of the sugar chains. Also provided are an endo-β-N-acetylglucosaminidase (Endo-Cp), an endo-β-N-acetylglucosaminidase (Endo-Pa) and an endo-β-N-acetylglucosamimidase (Endo Zr) which are produced fromDL-1 ATCC26012 strain,ATCC36904 strain andATCC2623 strain, respectively, on the basis of an Endo-Om gene sequence, and each of which has a similar level of complex type sugar chain cleavage activity and a similar level of complex type sugar chain transfer activity to those of Endo-Om.


Find Patent Forward Citations

Loading…